# NIH Reporter #11379002

Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer

**Recipient:** National Cancer Institute (NCI)

**Award Amount:** $641,673.00
**Ceiling:** $641,673.00

**Awarded:** September 15, 2026

**Identifier:** 11379002

This award funds a randomized trial to test a telehealth behavioral intervention (EASE) designed to reduce fear of progression and trauma symptoms in adults with advanced cancer, aiming to improve quality of life and mental health outcomes.

### Description

A randomized trial of a behavioral intervention called EASE, based on written exposure therapy, aimed at reducing fear of progression and cancer-related trauma symptoms among adults with advanced cancer. The trial compares EASE delivered via telehealth with usual care in a 2-arm study with 250 participants. The intervention is offered in English and Spanish and aims to improve quality of life, reduce anxiety, depression, and hopelessness, and inform evidence-based care guidelines.

[View original record](https://reporter.nih.gov/search/IgE1H2ioLUOz0qmA4MDg0Q/project-details/11379002)